EASTON BIOPHARMACEUTICALS(688513.SH)

Last Updated 00:00:00
longbridge loading

Pharmaceutical stocks fluctuated and surged, with Getein Biotech hitting the daily limit, RemeGen rising nearly 7%, reaching a historical high. Sunshine Guojian Pharmaceutical, EASTON BIOPHARMACEUTICALS, YKYY, Junshi Biosciences, BeBetter Med, and InventisBio also followed suit

Wallstreetcn·
SH
688336
-0.51%
SH
688513
+2.21%
HK
01877
-1.22%
Wallstreetcn·
SH
688336
-0.51%
SH
688513
+2.21%
HK
01877
-1.22%

EASTON BIOPHARMACEUTICALS: The company's hydrochloride deoxycorticosterone injection and beraprost sodium tablets are expected to be selected for national centralized drug procurement

Zhitong·
SH
688513
+2.21%
Zhitong·
SH
688513
+2.21%

EASTON BIOPHARMACEUTICALS released its performance for the first three quarters, with a net profit attributable to the parent company of 220 million yuan, a year-on-year increase of 1.45%

Zhitong·
SH
688513
+2.21%
Zhitong·
SH
688513
+2.21%

EASTON BIOPHARMACEUTICALS: Ailamod Tablets have obtained a drug registration certificate

Zhitong·
SH
688513
+2.21%
Zhitong·
SH
688513
+2.21%

SDKX and EASTON BIOPHARMACEUTICALS jointly expand the overseas market for Apalutamide tablets

Zhitong·
SH
688513
+2.21%
SH
688136
+3.37%
Zhitong·
SH
688513
+2.21%
SH
688136
+3.37%

EASTON BIOPHARMACEUTICALS: The hydrochloride ephedrine tablets have obtained a drug registration certificate

Zhitong·
SH
688513
+2.21%
Zhitong·
SH
688513
+2.21%

The pharmaceutical sector fell at the beginning of trading, with SUNFLOWER dropping 10%

Zhitong·
SZ
300204
+0.95%
SH
600276
-1.60%
SH
688513
+2.21%
Zhitong·
SZ
300204
+0.95%
SH
600276
-1.60%
SH
688513
+2.21%

Innovative drug concept stocks surged and then fell back, with Mengke Pharmaceutical dropping over 10%, BrightGene, Bio-S falling over 7%, and YKYY, Konruns, EASTON BIOPHARMACEUTICALS, Fushine among those with the largest declines

Zhitong·
SH
688166
-0.67%
SZ
301096
-1.64%
SH
688658
+2.37%
Zhitong·
SH
688166
-0.67%
SZ
301096
-1.64%
SH
688658
+2.37%

EASTON BIOPHARMACEUTICALS: Hydrochloride Arolol Tablets have obtained a drug registration certificate

Zhitong·
SH
688513
+2.21%
Zhitong·
SH
688513
+2.21%

Innovative drug concept stocks show partial strength, Thalys hits the limit up

Zhitong·
SH
603127
-1.89%
HK
06127
-3.75%
SZ
300436
+3.11%
Zhitong·
SH
603127
-1.89%
HK
06127
-3.75%
SZ
300436
+3.11%
© 2026 Longbridge｜Disclaimer